Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Takuya Harada
Institution:
National Center for Global Health and Medicine
Observed institutions:
Kyushu University,
University of Tsukuba,
National Kyushu Medical Center,
National Center for Global Health and Medicine,
The University of Osaka
ORCID:
0000-0002-8972-0316
Observed ORCID:
0000-0002-8972-0316
OpenAlex ID:
A5074706489
Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data
2020
·
Yasuo Mori
, Fumiaki Jinnouchi
, et al.
·
Bone Marrow Transplantation
·
68
TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia
2023
·
Teppei Sakoda
, Yoshikane Kikushige
, et al.
·
Blood Advances
·
47
PDF
WT1 peptide‐based immunotherapy for advanced thymic epithelial malignancies
2018
·
Yusuke Oji
, Masayoshi Inoue
, et al.
·
International Journal of Cancer
·
41
Risk factors for late cytomegalovirus infection after completing letermovir prophylaxis
2022
·
Yasuo Mori
, Takuya Harada
, et al.
·
International Journal of Hematology
·
31
Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease
2023
·
Takuya Harada
, Yoshikane Kikushige
, et al.
·
Nature Communications
·
22
PDF
Outcomes of methotrexate‐associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease‐modifying anti‐rheumatic drugs
2021
·
Takuya Harada
, Hiromi Iwasaki
, et al.
·
British Journal of Haematology
·
20
PDF
TIM ‐3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation
2024
·
Teppei Sakoda
, Yoshikane Kikushige
, et al.
·
Cancer Science
·
14
Predictors of impaired antibody response after SARS‐CoV ‐2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study
2022
·
Yasuo Mori
, Naoyuki Uchida
, et al.
·
American Journal of Hematology
·
14
Evaluation of TIM-3-Positive LSCs Post Allo-SCT Is a Highly Sensitive Strategy to Predict AML Relapses
2019
·
Teppei Sakoda
, Yoshikane Kikushige
, et al.
·
Blood
·
5
Immunology and targeted therapy in Castleman disease
2024
·
Shinichiro Tsunoda
, Takuya Harada
, et al.
·
Expert Review of Clinical Immunology
·
4
Successful allogeneic stem cell transplantation in a case with acute myeloid leukemia and invasive Schizophyllum commune rhinosinusitis
2020
·
Takuya Harada
, Takuro Kuriyama
, et al.
·
Journal of Infection and Chemotherapy
·
3
Somatic Mutations Potentiating RAS-MAPK Signaling Confer Resistant Potential Against FLT3-Inhibitors to Acute Myelogenous Leukemia
2019
·
Masayasu Hayashi
, Yoshikane Kikushige
, et al.
·
Blood
·
3
Use of tocilizumab to treat IgA nephropathy complicated by idiopathic multicentric Castleman disease: a case report
2025
·
Yuichiro Komeno
, Toshiaki Usui
, et al.
·
BMC Nephrology
·
2
PDF
Cricoarytenoid arthritis in rheumatoid arthritis
2020
·
Shinji Izuka
, Shunta Kaneko
, et al.
·
Rheumatology
·
2
Giant cell arteritis–associated temporomandibular joint arthritis confirmed by imaging
2026
·
Miyu Wakatsuki
, Hiroyuki Yamashita
, et al.
·
Rheumatology Advances in Practice
·
1
Comparison of quantitative PCR values and antigenemia for CMV monitoring in hematopoietic cell transplant recipients
2025
·
Yasuo Mori
, Kentaro Kohno
, et al.
·
International Journal of Hematology
·
1
Pericardial methotrexate-induced lymphoproliferative disorder in a patient with rheumatoid arthritis
2025
·
Miyu Wakatsuki
, Hiroyuki Yamashita
, et al.
·
Rheumatology Advances in Practice
·
1
PDF
A retrospective study describing the effective exchange of total blood plasma for disease control in the exacerbation of serpiginous choroiditis
2024
·
Yuri Katayama
, Daisuke Katagiri
, et al.
·
Therapeutic Apheresis and Dialysis
·
1
PDF
Lupus nephritis prolongs improvement of serositis in systemic lupus erythematosus
2024
·
Takuya Harada
, Hiroyuki Yamashita
, et al.
·
Joint Bone Spine
Evaluation of TIM-3+ AML stem cells should be significant to predict early relapses after allo-SCT
2019
·
Takuya Harada
·
The Japanese Society of Hematology
Show more works
View as search
Works count:
20
Citation count:
280
H-index:
8
I10-index:
8
Year
Topic
Type